Efficacy of RTS,S/AS02 malaria vaccine against Plasmodium falciparum infection in semi-immune adult men in The Gambia: a randomised trial
Top Cited Papers
- 1 December 2001
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 358 (9297) , 1927-1934
- https://doi.org/10.1016/s0140-6736(01)06957-4
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Efficacy of Recombinant Circumsporozoite Protein Vaccine Regimens against ExperimentalPlasmodium falciparumMalariaThe Journal of Infectious Diseases, 2001
- Potent Induction of Focused Th1‐Type Cellular and Humoral Immune Responses by RTS,S/SBAS2, a RecombinantPlasmodium falciparumMalaria VaccineThe Journal of Infectious Diseases, 1999
- Circumventing genetic restriction of protection against malaria with multigene DNA immunization: CD8+ cell-, interferon gamma-, and nitric oxide-dependent immunity.The Journal of Experimental Medicine, 1996
- Safety, Immunogenicity, and Efficacy of a Recombinantly Produced Plasmodium falciparum Circumsporozoite Protein-Hepatitis B Surface Antigen Subunit VaccineThe Journal of Infectious Diseases, 1995
- A Population-Based Clinical Trial with the SPf66 Synthetic Plasmodium falciparum Malaria Vaccine in VenezuelaThe Journal of Infectious Diseases, 1994
- Vaccination with SPf66, a chemically synthesised vaccine, against Plasmodium falciparum malaria in ColombiaThe Lancet, 1993
- Heterogeneity in survival analysisStatistics in Medicine, 1988
- The impact of heterogeneity on the comparison of survival timesStatistics in Medicine, 1987
- Safety and immunogenicity in man of a synthetic peptide malaria vaccine against Plasmodium falciparum sporozoitesNature, 1987
- SAFETY AND EFFICACY OF A RECOMBINANT DNA PLASMODIUM FALCIPARUM SPOROZOITE VACCINEThe Lancet, 1987